# 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

> **NCT05697159** · — · RECRUITING · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 20 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Sickness Behavior
- Inflammatory Disease
- Autoimmune
- Pain, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05697159
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-22
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05697159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05697159, "7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05697159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*